The global surgical stapling devices market was valued at USD 5.3 billion in 2023. Grand View Research estimates it at USD 6.9 billion in 2026 and projects USD 9.9 billion by 2030, a CAGR of 9.3% from 2024 to 2030.

  • Largest region (2023): North America, with a 29.9% revenue share
  • Fastest-growing region: Asia Pacific
  • Fastest-growing product, type and end-use: powered staplers, disposable devices and ambulatory surgical centers
  • Leading names: Johnson & Johnson, Medtronic, Intuitive Surgical and others

Surgical Stapling Devices Market Overview & Growth Drivers

The surgical stapling devices market is expanding because staplers now do work that sutures once did, and they do it faster. Roughly USD 4.6 billion in new revenue is expected between 2023 and 2030, based on the USD 5.3 billion and USD 9.9 billion figures.

Why staples are replacing sutures

Sutures were once the default for wound closure. Suturing takes longer and can lead to wound leakage and separation. Staplers offer speed, precision and dependable closure. This preference for staples over sutures is a core reason the surgical stapling devices market keeps growing.

Market projections referenced in this article are drawn from Grand View Research. To explore the data further, try their Prism AI tool.

Minimally invasive surgery, bariatrics and chronic disease

Three clinical trends reinforce each other. Minimally invasive surgery is spreading because smaller incisions mean less trauma, less postoperative pain and faster recovery. Bariatric procedures are rising, and staplers are central to them. Makers have also commercialized staplers tailored for endoscopic surgery, now used in gynecologic, thoracic and gastrointestinal procedures, as well as tissue and wound management.

Disease burden adds to the demand. A September 2023 WHO article attributes about 40 million deaths a year to non-communicable diseases, or 74% of all deaths. Cardiovascular disease alone claims 17.9 million lives annually. A patient pool that large keeps surgical volumes high, and the surgical stapling devices market benefits directly.

Innovation and consolidation

Innovation in this market is high and the growth stage is accelerating. Intuitive launched SureForm in India in June 2021, described as the first robotic-assisted stapler, with Smart Fire technology. Medtronic introduced its EEA Circular Stapler with Tri-Staple Technology in December 2020 for colorectal surgery, where leak-resistant anastomosis matters. M&A activity is moderate. Teleflex bought Standard Bariatrics for USD 170 million upfront in September 2022, which brought the Titan SGS system, a stapler that delivers a long, continuous staple line in a single firing.

Regulation shapes the pace too. The FDA cleared the SureForm 30 Curved-Tip Stapler, an 8 mm fully wristed device, in December 2021. Few external substitutes exist, gastric balloon systems being one example, so competition stays inside the category.

Download a free sample report or claim your copy of this full market intelligence report

Key Segments in the Surgical Stapling Devices Market

The market is segmented by product, type, end-use and region. The pattern across them is that the largest segment and the fastest-growing segment are often different.

By product, manual staplers held the largest revenue share in 2023. They are quick, precise compared with suturing, and cheaper than powered alternatives. Powered staplers are the faster-growing segment, at a 9.65% CAGR. They remove the need for manual firing force and come in several sizes, including circular and powered linear systems for complex procedures.

By type, disposable devices led in 2023 and are forecast to grow fastest at a 9.56% CAGR through 2030. Infection-control concerns drive this, and the CDC encourages disposable devices as part of its pathogen-control protocols. Reusable staplers will still grow at a significant rate. Stryker, Intuitive Surgical and Medtronic supply them, and in November 2020 Dolphin Sutures launched the reloadable, autoclavable DURAMATE in India.

By end-use, hospitals accounted for the largest revenue share in 2023, supported by favorable reimbursement and a growing hospital base. The American Hospital Association counted 6,120 U.S. hospitals in 2024, up from about 6,090 in 2020. Ambulatory surgical centers are the faster-growing channel, at a 9.54% CAGR. They offer cost-effective care, shorter stays and high procedure volumes.

By region, North America led in 2023 with a 29.9% share, backed by a high prevalence of cardiovascular disease and the presence of CONMED, 3M, Medtronic and Intuitive Surgical. Asia Pacific is the fastest-growing region, driven by chronic disease, rising incomes and aging populations. China is expected to grow fastest within the region, with domestic makers such as Changzhou Haida Medical competing alongside international firms. Japan and India are also forecast to grow at significant to lucrative rates. In Europe, the UK is projected to grow fastest, and Saudi Arabia is expected to lead growth in the Middle East & Africa.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs

Major Industry Players in the Surgical Stapling Devices Market

Grand View Research profiles ten companies: Johnson & Johnson Services, Inc.; Medtronic; Smith + Nephew; B. Braun SE; Intuitive Surgical Operations, Inc.; 3M; CONMED Corporation; BD (CareFusion Corporation); BioPro, Inc.; and Frankenman International Ltd.

Johnson & Johnson, through Ethicon, and Medtronic hold significant shares, helped by financial strength, established brands and wide distribution networks. J&J’s portfolio includes the ECHELON CIRCULAR Powered Stapler, the ETHICON Circular Stapler, the PROXIMATE PX Fixed-Head Skin Stapler and ECHELON FLEX ENDOPATH Staplers. In June 2022, Ethicon launched the ECHELON 3000 Stapler in the U.S., aimed at confined spaces and difficult tissue.

Intuitive Surgical competes through robotic integration rather than breadth. Teleflex is building a bariatric niche. It brought the Titan SGS Stapler with Staple Line Reinforcement to pre-order in January 2024, after FDA 510(k) clearance for the reinforcement in October 2023. Regulatory milestones also come from outside the U.S. In November 2023, TÜV Rheinland issued an MDR certificate for Ezisurg Medical’s Powered Endoscopic Stapler.

Explore the full list of profiled companies operating in this market with recent strategic initiatives

What the Numbers Signal

The growth segments sit close together. Powered (9.65%), disposable (9.56%) and ambulatory surgical centers (9.54%) all run only about 0.2 to 0.3 percentage points above the overall 9.3% CAGR. That suggests broad-based expansion across the surgical stapling devices market, not a single breakout segment. Manual staplers still lead on revenue because of cost, while powered devices lead on growth. Buyers appear to be paying for ergonomics only where budgets allow, which points to tiered adoption as the likely near-term pattern.

Final Takeaway

The surgical stapling devices market is on track to grow from USD 5.3 billion in 2023 to USD 9.9 billion by 2030. Minimally invasive surgery, bariatric demand and chronic disease drive that growth. Powered, disposable and outpatient-focused products are growing fastest, and the leading players are competing on robotics, bariatric innovation and regulatory clearances.

Check Out Our Dedicated Business Offerings –